You know there will be a buyout. Every hospital will have to stock this and a lot of drug companies will want a piece of that. Let the offers begin. $5.00, do I hear $6.
The real asset here in the technology to develop a broad range of respiratory products. IMHO, a buyout pps could be north of $15 or around $850M.
Unfortunately, that would still leave many long term holders with large losses. Such was the mismanagement here!